Eyetech Optimistic on FDA Meeting
337162
Biotech company Eyetech Pharmaceuticals Inc. said it is optimistic about the Food and Drug Administration&#39;s advisory panel review for its age-related blindness treatment Macugen.
232912
It would seem a drug executive&#39;s dream come true. A week ago Thursday, the secretary of health and human services summoned the top officials of MedImmune to his office in Washington to ask
694184
Eyetech Pharmaceuticals, a four-year-old company led by an ophthalmologist, Dr. David Guyer of New York University, has had excellent business vision.
602673
A Fool's prediction on the FDA's impending decision on approval.
193598
Three U.S. consumer products makers  will give a peek into their strategies this week and while the  sector has been plagued by rising costs and stiff competition,  analysts are optimistic about their prospects.
402091
Eyetech (EYET:Nasdaq - news - research) did not open for trading Friday because a Food and Drug Administration advisory committee is meeting to review the small New York-based biotech&#39;s experimental eye disease drug.
8068
Drug makers are exploring the possibility of tying pharmaceutical prices to performance.
414906
Eyetech Pharmaceuticals' drug to treat blindness in the elderly moved closer to government approval after an advisory panel to the F.D.A. spoke favorably about it.
51919
yetech Pharmaceuticals&#39; drug to treat the leading cause of blindness in the elderly appeared to move closer to a broad government approval yesterday after an advisory panel to the Food and Drug Administration spoke favorably about it.
87701
An implantable contact lens that corrects vision in nearsighted patients is safe and does not have some of the side-effects of laser surgery, a company that manufactures the devices said on Wednesday.
423500
Company is working on flexible display technologies.
671344
NEWYORK: US technology executives are increasingly optimistic about the business climate, although plans for increased technology spending remain modest, according to a study.
147168
The approval of a new drug is a long-term opportunity.
177682
Genentech appears to have resolved a dispute with ophthalmologists that will allow its drug Avastin to continue to be used to treat eye diseases, boths sides said.
409761
Genzyme shows some sparkle at investors' conference.
607304
Food and Drug Administration approvals kept medical device and drug company stocks in the spotlight with two device companies reporting product approvals Wednesday.
260506
Implantable contact lenses are a safe and effective way to correct moderate to high nearsightedness, says a study in the September issue of Ophthalmology.